FY2025 EPS Estimates for 23448 (LAB.TO) Raised by Alliance Global Partners (TSE:LAB)

23448 (LAB.TO) (TSE:LAB) – Analysts at Alliance Global Partners raised their FY2025 earnings per share (EPS) estimates for shares of 23448 (LAB.TO) in a research report issued on Thursday, August 15th. Alliance Global Partners analyst A. Grey now forecasts that the company will earn $0.00 per share for the year, up from their prior estimate of ($0.01).

23448 (LAB.TO) Price Performance

23448 (LAB.TO) Company Profile

Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies.